Early diagnosis of autoimmune rheumatic diseases (ARD) is key to achieving effective treatment and improved prognosis. The coronavirus disease 2019 (COVID-19) pandemic has led to major changes in clinical practice on a global scale. We aimed to evaluate the impact of the COVID-19 pandemic on rheumatological clinical practices and autoimmunity testing demands.

中文翻译：

---

COVID-19 大流行对自身免疫性疾病诊断途径适当性的影响。

自身免疫性风湿病 (ARD) 的早期诊断是实现有效治疗和改善预后的关键。2019 年冠状病毒病 (COVID-19) 大流行导致全球临床实践发生重大变化。我们旨在评估 COVID-19 大流行对风湿病临床实践和自身免疫测试需求的影响。